‘Mass-Produced Gene-Edited Babies’: Sam Altman and Husband Funding New BioLab Venture

When news broke that OpenAI’s Sam Altman and his husband Oliver Mulherin had thrown their weight behind a new startup focused on genetically engineering babies, the tech world applauded. But beyond the applause, in darker corners of the internet, a far more unsettling narrative began to emerge.

The startup, Preventive, has raised $30 million and established its headquarters in San Francisco, promising to “address devastating genetic conditions.” To biotech optimists, it’s a noble vision. To critics, it is something else entirely: the prototype for a future where elite-funded labs design the next generation of humanity—outside democratic oversight, outside public scrutiny, and outside moral boundaries.

And if the dystopian fear feels exaggerated, consider the bigger picture: Preventive’s mission is currently illegal in the U.S., UK, and many other countries.

So why would some of the most powerful men in tech be funneling money into something governments have explicitly banned?

A New Frontier — or a New Industry of Manufactured Humans?

Preventive’s pitch is simple: use gene editing on human embryos to eliminate hereditary diseases before birth. A modern miracle, at face value.

But critics warn that once the technology exists, the step from “eliminating disease” to “engineering traits” is not just small—it is inevitable.

Height. Intelligence. Personality. Physical strength. Once the door opens, it never closes. And that door is opening in the shadows.

According to reporting shared in The Times, Coinbase CEO Brian Armstrong is investing alongside Altman and Mulherin, calling the project a necessary leap forward:

“More than 300 million people globally live with genetic disease… Research should determine if safe therapies can be developed to cure these diseases at birth.”

That may sound ethical. But critics ask a darker question:

Cure diseases for whom? And controlled by whom?

The UAE Option: Testing What the West Won’t Allow

Because gene-edited babies are illegal in the U.S. and most Western nations, The Wall Street Journal noted that Preventive was exploring a controversial workaround:
using the United Arab Emirates as a testing ground, since embryo editing is permitted there.

Opponents see a dystopian pattern:

1. Powerful tech elites fund a radical bio-lab project.
2. They take it offshore to avoid regulation and oversight.
3. They test the first generation of engineered children on foreign soil.
4. They introduce their results back into the West as a “breakthrough.”

If that sounds familiar, it’s because that’s how many industries—from pharmaceuticals to finance—have historically circumvented ethical barriers.

Now imagine that same pattern applied not to drugs, but to human beings.

The First Volunteers: A Couple Willing to Let Scientists Alter Their Child’s DNA

According to reports, Preventive’s scientists are already in discussions with a couple who carry a genetic disease and are willing to participate in an embryo-editing experiment.

Even supporters admit this would be the first human life ever created through their system.

Critics argue it would also be the first human life created at the mercy of venture-capital interests.

In a world where tech CEOs already shape our information, our money, and our political discourse…
should they also shape our biology?

The Altman Factor: AI + Genetic Engineering

Perhaps the most chilling element isn’t the gene editing itself, but the people involved.

Sam Altman isn’t just a wealthy investor. He is the public face of artificial intelligence, a technology already reshaping global power structures.

Now imagine the same people steering AI also steering human evolution.

Imagine AI-optimized gene-selection algorithms deciding:

• which embryos survive
• which traits are “preferable”
• which lives are worth creating

To critics, Preventive looks less like a medical project… and more like the first battleground of a post-human future.